- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 6 residues within 4Å:- Chain A: N.159
- Chain C: S.213, P.215, R.216, N.219
- Ligands: NAG.7
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.219, C:R.216, C:R.216, C:R.216
NAG-NAG-BMA.10: 6 residues within 4Å:- Chain C: N.159
- Chain E: S.213, P.215, R.216, N.219
- Ligands: NAG.15
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:N.219, E:R.216, E:R.216, E:R.216
NAG-NAG-BMA.18: 6 residues within 4Å:- Chain A: S.213, P.215, R.216, N.219
- Chain E: N.159
- Ligands: NAG.23
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.219, A:R.216, A:R.216, A:R.216
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.3: 5 residues within 4Å:- Chain A: S.39, N.279, V.291, N.292
- Chain B: E.69
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 5 residues within 4Å:- Chain C: S.39, N.279, V.291, N.292
- Chain D: E.69
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 5 residues within 4Å:- Chain E: S.39, N.279, V.291, N.292
- Chain F: E.69
No protein-ligand interaction detected (PLIP)- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 4 residues within 4Å:- Chain A: N.16, T.18, T.31, N.32
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: E.56, N.57, Y.88
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain A: Q.126, N.127
Ligand excluded by PLIPNAG.7: 8 residues within 4Å:- Chain A: A.157, L.158, N.159, R.195, N.240, S.241, T.242
- Ligands: NAG-NAG-BMA.2
Ligand excluded by PLIPNAG.8: 4 residues within 4Å:- Chain B: A.147, G.150, S.151, N.154
Ligand excluded by PLIPNAG.12: 4 residues within 4Å:- Chain C: N.16, T.18, T.31, N.32
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain C: E.56, N.57, Y.88
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain C: Q.126, N.127
Ligand excluded by PLIPNAG.15: 8 residues within 4Å:- Chain C: A.157, L.158, N.159, R.195, N.240, S.241, T.242
- Ligands: NAG-NAG-BMA.10
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain D: A.147, G.150, S.151, N.154
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain E: N.16, T.18, T.31, N.32
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain E: E.56, N.57, Y.88
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain E: Q.126, N.127
Ligand excluded by PLIPNAG.23: 8 residues within 4Å:- Chain E: A.157, L.158, N.159, R.195, N.240, S.241, T.242
- Ligands: NAG-NAG-BMA.18
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain F: A.147, G.150, S.151, N.154
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wu, N.C. et al., A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. (2017)
- Release Date
- 2017-10-18
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wu, N.C. et al., A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. (2017)
- Release Date
- 2017-10-18
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B